๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Acyl CoA:cholesterol acyltransferase (ACAT) inhibitors: ureas bearing two heterocyclic head groups

โœ Scribed by Richard G. Wilde; Jeffrey T. Billheimer


Book ID
103982817
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
232 KB
Volume
5
Category
Article
ISSN
0960-894X

No coin nor oath required. For personal study only.

โœฆ Synopsis


A series of compounds bearing two heterocyclic substituents were prepared, and evaluated for inhibition of aeyl-CoA:cholesterol acyltransferase (ACAT). The heterocyclic groups were chosen for dual potency against hepatic and macrophage cell ACAT. Several examples of ACAT-balanced compounds were discovered, and the results of this study, including synthesis, are presented.


๐Ÿ“œ SIMILAR VOLUMES


Pyridazine derivatives as novel acyl-coa
โœ Arianna Gelain ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› Journal of Heterocyclic Chemistry ๐ŸŒ English โš– 96 KB

Acyl-CoA:cholesterol acyltransferase (E.C.2.3.1.26, ACAT) is a microsomial enzyme that catalyses the formation of cholesteryl esters by acylation of cholesterol with long chain fatty acylCoA [1]. ACAT plays important roles in cellular homeostasis and in the early stages of atherosclerosis. Therefor

Tetrazole-substituted ureas as inhibitor
โœ Claude F Purchase II; Andrew D White; Maureen K Anderson; Thomas M.A Bocan; Rich ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 327 KB

A novel series of tetrazole-substituted ureas 2 were prepared from weakly nucleophilic amines using a new coupling method. The ureas were found to potently inhibit liver ACAT in vitro and lower total serum cholesterol in vivo. A comparison of urea 2b and the anti-atherosclerotic CI-976 in a long-ter